Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

NCT02856178 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped study no longer required

Conditions

Pulmonary Aspergillosis - Invasive
Acute Myeloid Leukemia

Interventions

DRUG: F901318
DRUG: Caspofungin

Sponsor

F2G Ltd

Collaborators

[object Object]